Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update

National recommendations on continued administration of aflibercept solution for injection after the first year of treatment for neovascular age-related macular degeneration (nAMD) have been developed by an expert panel of UK retina specialists, based on clinician experience and treatment outcomes s...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Praveen J, Devonport, Helen, Sivaprasad, Sobha, Ross, Adam H, Walters, Gavin, Gale, Richard P, Lotery, Andrew J, Mahmood, Sajjad, Talks, James S, Napier, Jackie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685136/
https://www.ncbi.nlm.nih.gov/pubmed/29184385
http://dx.doi.org/10.2147/OPTH.S145732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685136/
https://www.ncbi.nlm.nih.gov/pubmed/29184385
http://dx.doi.org/10.2147/OPTH.S145732

Ejemplares similares